1. Home
  2. INUV vs TVGN Comparison

INUV vs TVGN Comparison

Compare INUV & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$0.59

Market Cap

18.0M

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$7.81

Market Cap

21.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
INUV
TVGN
Founded
N/A
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Blank Checks
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.0M
21.3M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
INUV
TVGN
Price
$0.59
$7.81
Analyst Decision
Strong Buy
Hold
Analyst Count
4
1
Target Price
$11.00
N/A
AVG Volume (30 Days)
164.3K
6.5K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
N/A
N/A
Revenue
$86,209,305.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.89
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.88
N/A
52 Week Low
$0.57
$0.14
52 Week High
$4.42
$12.03

Technical Indicators

Market Signals
Indicator
INUV
TVGN
Relative Strength Index (RSI) 30.93 67.37
Support Level N/A $6.22
Resistance Level $1.16 $7.90
Average True Range (ATR) 0.04 0.41
MACD 0.01 0.04
Stochastic Oscillator 18.47 88.98

Price Performance

Historical Comparison
INUV
TVGN

About INUV Inuvo Inc.

Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: